Evidence map›Paper›PMID 36128518›Full record

ArticleRSC advances2022

MWCNT modified Ni-Fe LDH/BiVO

Xuejun Qi, Shuyan Tao

Open access · goldAbstract read
In one paragraph

Article in RSC advances, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.3field-weighted citation impact, top 53% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 9 citations in OpenAlex.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Xuejun QiSchool of Architecture and Civil Engineering, Xihua University Chengdu 610039 PR China xuejunqi@hotmail.com.ORCID https://orcid.org/0000-0001-7989-2977
Shuyan TaoSchool of Architecture and Civil Engineering, Xihua University Chengdu 610039 PR China xuejunqi@hotmail.com.
Xihua University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Sensitivity and selectivity, which can be identified by the photosensitivity of materials and the identification of elements, are two important factors for a photoelectrochemical aptasensor (PEC aptasensor). Herein, a patent PEC aptasensor for specifically detecting ofloxacin (OFL) was exploited, and a visible-light-active MWCNT/LDH/BiVO

Identifiers

PMID36128518
PMCPMC9412155
OpenAlexW4293111970

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.